LunaVax Insights: Nigeria Launches Africa’s Largest Vaccination Campaign

A historic national effort.

Nigeria has launched Africa’s largest integrated health campaign, targeting nearly 100 million children with life-saving vaccines and treatments. From measles-rubella and HPV to polio, routine childhood vaccines, NTD interventions, and malaria SMC, this coordinated nationwide push aims to close long-standing immunity gaps across all 36 states.

The campaign is rolling out in two phases, with Phase 1 already underway across northern states and Phase 2 scheduled for early 2026 in the southern regions.

Flagged off by the First Lady in Abuja and led by the Federal Ministry of Health and Social Welfare and NPHCDA, the campaign marks one of the most ambitious immunization drives ever undertaken on the continent.

A shared mission.

This national effort also highlights a critical opportunity: ensuring that future immunization programs become faster, simpler, and more resilient. With millions of caregivers and frontline workers mobilized across the country, innovations like microneedle vaccine patches (MAPs) and digital identification can ease workload, improve accuracy, and support outreach where traditional cold-chain systems face the greatest strain.

LunaVax is working with partners across Lagos, Abuja, and beyond to advance MAP and biometric innovations so every child can receive life-saving vaccines, simply and reliably.

As Nigeria scales this historic national effort, LunaVax is contributing to what comes next by supporting MAP and biometric innovation and helping develop one of the world’s early Phase III–aligned study frameworks for MAPs, guided by WHO direction and positioned for large-scale evaluation in Nigeria.